Podcast—Collaborative Innovation: The Role of CROs and CDMOs in the Future of Drug Development

This discussion highlights the transformative impact of CRO and CDMO collaborations on the pharmaceutical industry, especially in the context of NCEs, NBEs, and ADCs. It examines how these partnerships foster innovation, from discovery through to commercialization, and how they can be strategically utilized to overcome common bottlenecks in drug development. The session will also delve into the integration of new technologies and methodologies within these collaborations, showcasing how they contribute to streamlined processes, reduced time to market, and, ultimately, a more efficient pathway to deliver breakthrough therapies to patients.

00:23—Navigating the Economic Landscape
03:19—Trends in Development Strategies
06:04—The Importance of Decision-Making
10:39—Partnership Dynamics in CDMO Relationships
15:43—Lessons from the COVID Era
17:59—The Future of Development Tools
20:40—Market Dynamics and Drug Approvals
24:02—Personalized Medicine and mRNA Therapy
32:31—Innovation Adoption in CDMOs
34:16—M&A Trends in the Pharmaceutical Industry
35:47—Investor Trends and Asset-Light Innovations
37:37—The New Normal in Investment Strategies
40:04—Opportunities for Biotech Amid Patent Cliffs
43:08—Impact of Increased Investment in Pharma Services
46:34—The Rise of Blockbuster Molecules
51:18—Manufacturing Demand for GLP-1s
53:02—Future of Pharma Ecosystem and Innovation
55:14—Economic Impact of GLP-1 Products
57:39—Future of the CDMO Industry
1:05:33—Emerging Therapies: mRNA and Beyond
1:10:07—Balancing Innovation with Established Medications

Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements.